Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis.
about
HDL-S1P: cardiovascular functions, disease-associated alterations, and therapeutic applicationsEvolving concepts in cancer therapy through targeting sphingolipid metabolismAtheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P)Sphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progressInhibition of doxorubicin-induced senescence by PPARδ activation agonists in cardiac muscle cells: cooperation between PPARδ and Bcl6Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injuryExogenous expression of human apoA-I enhances cardiac differentiation of pluripotent stem cells.Apolipoprotein M modulates erythrocyte efflux and tubular reabsorption of sphingosine-1-phosphate.RISK and SAFE signaling pathway involvement in apolipoprotein A-I-induced cardioprotectionImproving heart function by modulating myocardiocyte autophagy: a possible novel mechanism for cardiovascular protection of high-density lipoproteinHigh density lipoprotein: it's not just about lipid transport anymoreStat3: friend or foe in colitis and colitis-associated cancer?Antitumor Activity of a Novel Sphingosine-1-Phosphate 2 Antagonist, AB1, in Neuroblastoma.Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43.High density lipoprotein/sphingosine-1-phosphate-induced cardioprotection: Role of STAT3 as part of the SAFE pathway.Unraveling the complexities of the HDL lipidomeWhen are pro-inflammatory cytokines SAFE in heart failure?Role of sphingosine 1-phosphate in anti-atherogenic actions of high-density lipoprotein.Effect of mesenchymal stem cells on Doxorubicin-induced fibrosis.Impact of repeated intravenous bone marrow mesenchymal stem cells infusion on myocardial collagen network remodeling in a rat model of doxorubicin-induced dilated cardiomyopathy.High density lipoprotein (HDL) reverses palmitic acid induced energy metabolism imbalance by switching CD36 and GLUT4 signaling pathways in cardiomyocyte.High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate.HDL protects against doxorubicin-induced cardiotoxicity in a scavenger receptor class B type 1-, PI3K-, and Akt-dependent manner.Pharmacological Intervention to Modulate HDL: What Do We Target?High-density lipoprotein-associated sphingosine-1-phosphate activity in heterozygous familial hypercholesterolaemia.High-density lipoprotein protects cardiomyocytes against necrosis induced by oxygen and glucose deprivation through SR-B1, PI3K, and AKT1 and 2.Proteomic and lipidomic analyses of paraoxonase defined high density lipoprotein particles: Association of paraoxonase with the anti-coagulant, protein S.The effects of curcumin post-treatment against myocardial ischemia and reperfusion by activation of the JAK2/STAT3 signaling pathway.Elimination of established tumors with nanodisc-based combination chemoimmunotherapy.Cardioprotective Effects of High-Density Lipoprotein Beyond its Anti-Atherogenic Action
P2860
Q26779667-BF448C3A-96F3-467B-8004-CD7AB1027219Q26863646-0900A961-9190-400A-A521-56C9F1BCE985Q27000801-608BA5B2-3606-47E6-930E-79085592C4BDQ27001065-34D2EF6B-A925-42C0-B10E-7A07C5485251Q28484007-B0E5B242-A7B8-42C4-AE5C-A916005E8C5DQ28544407-3C39A647-2DDB-4B3D-8036-A9FD6FE9C269Q33904083-6A5422A9-63F9-4B4A-840E-055CCBC347FEQ33945112-6BDC0029-3B2A-41D9-8B80-2A905CDEA1F9Q34215871-12F36D6F-8A75-4633-8BE0-160E5C4386F2Q34439003-90E4BD39-856E-428B-871F-FB262B7DD5A2Q34565254-2AEDFC92-AEA7-41D3-B4D2-4E75579BB03EQ35596933-7C890DF1-03CF-4873-93AA-514D5502C812Q35962030-65FF6F88-1FDE-4572-96AC-32602536BF24Q36575703-CF4C560B-2D70-4CB9-BBD8-C537D31E09BFQ36895483-7F348FAA-D3DD-44A7-BBEC-757E40226EF4Q37222656-4B760EF4-60F5-44C8-8463-24CE16A73DAAQ37838085-16B8BFFF-E5EB-45FE-8788-AAE4A748C7A4Q37871354-363F1511-2DE8-4769-9088-B2817F8894D8Q42217160-833C7580-4A79-4BF0-B44D-026A9D02B8E6Q44081103-2F4C5913-142C-413B-8887-2A14A439AED9Q48061653-134979BB-5132-419F-BCFA-68FA02C8F789Q48233467-C637E9B6-F2A7-47C7-9764-2DC00336BDAEQ49548633-99F79D4D-2ABE-4B3B-AF3B-81C34D590B31Q49554117-BE663E11-31FA-4589-AE48-F148548C8317Q51319140-5B1F5F87-2DBB-47F0-B46B-260F9DCCDD5BQ52663632-47EE6FEA-15FC-4B7B-B8B6-26AB807C05FFQ53727498-A024DAAF-41A4-4A8C-96ED-8EFCFFF1695DQ54519859-2385C01D-D739-40BE-8EE0-4FFFAF00780AQ55044963-4E133A76-6F10-48B4-95AA-3D8B8F429BD9Q58791389-E32087B5-4F68-4051-B14F-8C7B39370E84
P2860
Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis.
@en
Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis.
@nl
type
label
Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis.
@en
Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis.
@nl
prefLabel
Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis.
@en
Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis.
@nl
P2093
P2860
P356
P1476
Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis.
@en
P2093
Christine Gerber-Wicht
Miguel A Frias
Richard W James
Ursula Lang
P2860
P304
P356
10.1093/CVR/CVP289
P577
2010-01-01T00:00:00Z